Stefan J Hutten

6PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Stefan J Hutten, Xue Chao, Madelon Badoux

|Oct 21, 2025
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State.

Youssef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba

|Apr 30, 2025
Large-scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.

Catrin Lutz, Xue Chao, Bim de Klein

|Sep 04, 2024
Mechanisms that clear mutations drive field cancerization in mammary tissue.

Marta Ciwinska, Hendrik A Messal, Hristina R Hristova

|May 23, 2024
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.

Stefan J Hutten, Hendrik A Messal, Esther H Lips

|Aug 24, 2023
MIND the translational gap: Preclinical models of ductal carcinoma in situ.

Stefan J Hutten, Jos Jonkers

Pageof 1

Frequent Collaborators

6 joint publications

Jos Jonkers

4 joint publications

Colinda Lgj Scheele

3 joint publications

Jacco van Rheenen

2 joint publications

Hendrik A Messal